Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Computer device with digitizer calibration system and method
Hand sign
Organic light emitting display device and method of manufacturing the same
Device and method incorporating an improved text input mechanism
Method for preparing an organic film at the surface of solid support under non-electrochemical conditions, solid support thus obtained and preparation kit
Wiring structure in a semiconductor device, method of forming the wiring structure, semiconductor device including the wiring structure and method of manufacturing the semiconductor device
Process for preparing MDA via the stage of the aminal
  Randomly Featured Patents
Prism device and combined optical and radio frequency beam steering system
Programmable display controller
Apparatus for disposing of medical waste by crushing
Inherently de-coupled sandwiched solenoidal array coil
Air conditioning system for a mobile home including an interlock
Pipe clamp
Key button arrangement for a handset
Programmed release oral solid pharmaceutical dosage form
Image reading apparatus, and image forming apparatus